Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Latest filing published 02 Apr 2013 for NxStage Medical, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
7
Signal history
No signal scores available.
Philippe O. Chambon: trading record in brief
Filings by Philippe O. Chambon span 3 companies, the busiest being NxStage Medical, Inc., Auxilium Pharmaceuticals Inc and Epocrates Inc. In total, 27 filings cover trades dated from 31 March 2011 to 29 March 2013.
No open-market purchase appears, only 7 sales worth €3.6M. Outside the open market, there are 13 share grants and 2 option exercises.
Most recently, on 2 April 2013, the filings show a share grant in NxStage Medical, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Philippe O. Chambon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
1,041 shares0Common StockSEC:0001012975-13-000131:0
2,644,170 sharesCommon StockSEC:0001096738-13-000022:0
1,044 shares0Common StockSEC:0001012975-13-000012:0
907 shares0Common StockSEC:0001012975-12-000271:0
1,101 shares0Common StockSEC:0001012975-12-000221:0
2,442 shares@ US$12.20Common StockSEC:0001012975-12-000160:0
635 shares0Common StockSEC:0001209191-12-021454:0
74,401 shares@ US$19.28Common StockSEC:0001012975-12-000082:0
22,473 shares@ US$18.94Common StockSEC:0001012975-12-000046:0
863,676 shares@ US$17.86Common StockSEC:0001012975-12-000002:0
773 shares0Common StockSEC:0001209191-12-000633:0
491 shares0Common StockSEC:0001209191-11-050309:0
20,110 shares@ US$18.58Common StockSEC:0001012975-11-000263:0
53,102 shares@ US$18.42Common StockSEC:0001012975-11-000253:0
57,480 shares@ US$18.47Common StockSEC:0001012975-11-000247:0
2,085 shares@ US$18.52Common StockSEC:0001012975-11-000247:1
112,862 shares@ US$5.50Common StockSEC:0001012975-11-000247:2
34,892 shares@ US$17.79Common StockSEC:0001012975-11-000247:3
1,092,830 shares@ US$18.46Common StockSEC:0001012975-11-000237:0
756 shares0Common StockSEC:0001209191-11-037260:0
21,726 shares@ US$21.77Common StockSEC:0001012975-11-000156:0
718,858 shares@ US$23.00Common StockSEC:0001012975-11-000132:0
697 shares@ US$21.47Common StockSEC:0001181431-11-029483:0
466 shares0Common StockSEC:0001209191-11-021040:0
174 shares@ US$21.47Common StockSEC:0001209191-11-021300:0
25 of 25 declarations
